000 01608 a2200445 4500
005 20250515203619.0
264 0 _c20100309
008 201003s 0 0 eng d
022 _a1538-2990
024 7 _a10.1097/MAJ.0b013e3181c4bd91
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRabinowits, Guilherme
245 0 0 _aFixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neck.
_h[electronic resource]
260 _bThe American journal of the medical sciences
_cFeb 2010
300 _a148-51 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCapecitabine
650 0 4 _aCarcinoma, Squamous Cell
_xdrug therapy
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHead and Neck Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOrganoplatinum Compounds
_xadministration & dosage
650 0 4 _aOxaliplatin
650 0 4 _aPalliative Care
650 0 4 _aPilot Projects
700 1 _aBhupalam, Leela
700 1 _aMiller, Donald M
700 1 _aKloecker, Goetz H
700 1 _aLaber, Damian A
773 0 _tThe American journal of the medical sciences
_gvol. 339
_gno. 2
_gp. 148-51
856 4 0 _uhttps://doi.org/10.1097/MAJ.0b013e3181c4bd91
_zAvailable from publisher's website
999 _c19464093
_d19464093